For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Summary
Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the "pump", and does the work of the heart and lungs during the operation.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Artificial Heart Lung Machines , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and By major regions).
The report provides introduction of leading Global manufacturers.
Artificial Heart Lung Machines market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Russia, Spain etc)
- Asia-Pacific (China, India, Japan, Southeast Asia etc)
- South America (Brazil, Argentina etc)
- Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
- Single Roller Pump HLM
- Double Roller Pump HLM
By End-User / Application
- Cardiac Surgery
- Lung Transplant Operation
- Acute Respiratory Failure Treatment
- Others
By Company
- LivaNova (Sorin)
- Getinge (Maquet)
- Medtronic
- Terumo CV Group
- Braile Biomedica
- Tianjin Medical